Skip to content
10-Q

Quarterly Report

XERIS BIOPHARMA HOLDINGS, INC. XERS

0001867096-25-000136

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 161.48M sh
Shares Diluted Q2 2025 · Jun 30, 2025 159.46M sh
Shares Diluted Q2 2025 · Jun 30, 2025 155.97M sh
Shares Diluted Q2 2025 · Jun 30, 2024 148.35M sh
Shares Diluted Q2 2025 · Jun 30, 2024 144.37M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$9.85M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$30.65M
Long Term Debt Q2 2025 · Jun 30, 2025 $218.63M
Long Term Debt Q2 2025 · Dec 31, 2024 $217.01M
Short Term Debt Q2 2025 · Jun 30, 2025 $0
Short Term Debt Q2 2025 · Dec 31, 2024 $15.1M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $59.29M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $71.62M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $57.6M
Stockholders Equity Q2 2025 · Jun 30, 2025 −$19.3M
Stockholders Equity Q2 2025 · Mar 31, 2025 −$35.13M
Stockholders Equity Q2 2025 · Dec 31, 2024 −$29.62M
Stockholders Equity Q2 2025 · Jun 30, 2024 −$19.29M
Stockholders Equity Q2 2025 · Mar 31, 2024 −$9.18M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$6.78M
Current Liabilities Q2 2025 · Jun 30, 2025 $95.17M
Current Liabilities Q2 2025 · Dec 31, 2024 $100.44M
Total Liabilities Q2 2025 · Jun 30, 2025 $353.99M
Total Liabilities Q2 2025 · Dec 31, 2024 $352.68M
Current Assets Q2 2025 · Jun 30, 2025 $185.58M
Current Assets Q2 2025 · Dec 31, 2024 $167.66M
Total Assets Q2 2025 · Jun 30, 2025 $334.69M
Total Assets Q2 2025 · Dec 31, 2024 $323.06M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.01
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.07
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.10
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.24
Eps Basic Q2 2025 · Jun 30, 2025 −$0.01
Eps Basic Q2 2025 · Jun 30, 2025 −$0.07
Eps Basic Q2 2025 · Jun 30, 2024 −$0.10
Eps Basic Q2 2025 · Jun 30, 2024 −$0.24
Sga Expense Q2 2025 · Jun 30, 2025 $44.39M
Sga Expense Q2 2025 · Jun 30, 2025 $88.41M
Sga Expense Q2 2025 · Jun 30, 2024 $39.99M
Sga Expense Q2 2025 · Jun 30, 2024 $78.37M
Rd Expense Q2 2025 · Jun 30, 2025 $8.06M
Rd Expense Q2 2025 · Jun 30, 2025 $15.81M
Rd Expense Q2 2025 · Jun 30, 2024 $5.76M
Rd Expense Q2 2025 · Jun 30, 2024 $13.58M
Net Income Q2 2025 · Jun 30, 2025 −$1.93M
Net Income Q2 2025 · Jun 30, 2025 −$11.15M
Net Income Q2 2025 · Mar 31, 2025 −$9.22M
Net Income Q2 2025 · Jun 30, 2024 −$15.01M
Net Income Q2 2025 · Jun 30, 2024 −$33.99M
Net Income Q2 2025 · Mar 31, 2024 −$18.98M
Operating Income Q2 2025 · Jun 30, 2025 $4.48M
Operating Income Q2 2025 · Jun 30, 2025 $1.39M
Operating Income Q2 2025 · Jun 30, 2024 −$8.19M
Operating Income Q2 2025 · Jun 30, 2024 −$22.43M
Revenue Q2 2025 · Jun 30, 2025 $71.54M
Revenue Q2 2025 · Jun 30, 2025 $131.66M
Revenue Q2 2025 · Jun 30, 2024 $48.07M
Revenue Q2 2025 · Jun 30, 2024 $88.7M